Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-0540-2014

Medfusion® 4000 Syringe Infusion Pumps Medfusion® 4000 Syringe Infusion Pumps are designed for use in care areas for the administration of fluids requiring precisely controlled infusion rates. These pumps are indicated for use by healthcare professionals in the delivery of IV solutions, drug solutions, blood or blood products, and enteral feedings in continuous, intermittent, and body weight delivery modes.

Publicado el 25 de diciembre de 2013 · Inicio del retiro: 22 de noviembre de 2013

Resumen

FDA registra el retiro Z-0540-2014 de dispositivos médicos de Clase II, publicado el 25 de diciembre de 2013 e iniciado el 22 de noviembre de 2013. Empresa responsable: Smiths Medical ASD, Inc.; Estado: Finalizado; Cantidad reportada: 9560 (8601 US, 959 OUS); Lote: All Medfusion® 4000 Syringe Pumps in the field are affected by this Field Safety Corrective Action. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Smiths Medical is conducting a recall involving all Medfusion® 4000 Syringe Infusion Pumps. Smiths Medical has identified an issue with electrical shorting at the AC power receptacle. Shorting can occur when saline solution or other conductive fluids (e.g., potassium chloride) enter the AC power receptacle. When this happens, sparking and/ or flames, accompanied by smoke, may appear at the AC po

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Smiths Medical ASD, Inc.
Distribuidor
Worldwide Distribution - USA (nationwide ) including the states of : AZ, NY, TN, MS, AR, WV, VA, VT, PA, DE, DC, OH, CO, NH, MI, CA, FL, CT, WA, MD, NM, RI, MA, TX, NC, IL, KY, WI and MI., and the countries of CANADA, SAUDI ARABIA and AUSTRALIA.
Lote
All Medfusion® 4000 Syringe Pumps in the field are affected by this Field Safety Corrective Action.
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Medfusion® 4000 Syringe Infusion Pumps Medfusion® 4000 Syringe Infusion Pumps are designed for use in care areas for the administration of fluids requiring precisely controlled infusion rates. These pumps are indicated for use by healthcare professionals in the delivery of IV solutions, drug solutions, blood or blood products, and enteral feedings in continuous, intermittent, and body weight delivery modes. fue retirado del mercado?

Sí. FDA publicó el retiro Z-0540-2014 el 25 de diciembre de 2013. Peligro reportado: Smiths Medical is conducting a recall involving all Medfusion® 4000 Syringe Infusion Pumps. Smiths Medical has identified an issue with electrical shorting at the AC power receptacle. Shorting can occur when saline solution or other conductive fluids (e.g., potassium chloride) enter the AC power receptacle. When this happens, sparking and/ or flames, accompanied by smoke, may appear at the AC po

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter